Eivind Nielsens takmalerier i nationaltheatret

Autor: Hauge, Eva

Publikováno v: Hauge, Eva. Eivind Nielsens takmalerier i nationaltheatret. Masteroppgave, University of Oslo, 2013

Externí odkaz: http://hdl.handle.net/10852/37361
https://www.duo.uio.no/bitstream/handle/10852/37361/1/haugexmasterx2013.pdf

Valrubicin activates PKCa in keratinocytes:a conceivable mode of action in treating hyper-proliferative skin diseases

Autor: Laugesen, Ina Groenkjaer, Hauge, Eva, Andersen, Stine Maria, Stenderup, Karin, de Darkó, Elisabeth, Dam, Tomas Norman, Rosada, Cecilia

Publikováno v: Laugesen, I G, Hauge, E, Andersen, S M, Stenderup, K, de Darkó, E, Dam, T N & Rosada, C 2013, ' Valrubicin activates PKCa in keratinocytes : a conceivable mode of action in treating hyper-proliferative skin diseases ', Journal of Drugs in Dermatology, vol. 12, no. 10, pp. 1156-62 .

Valrubicin is a semisynthetic anthracycline developed as an anti-cancer drug able to ameliorate psoriasis and non-melanoma skin cancer (NMSC) by topical application in animal models. Valrubicin decreases cell proliferation, and induces apoptosis; how

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pure_au_____::3733c530f885b3c2c80607c443db16cc
https://pure.au.dk/portal/da/publications/valrubicin-activates-pkca-in-keratinocytes(af9378d9-09b2-4b0e-b4e3-cb4cc63ef88e).html

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Valrubicin activates PKCa in keratinocytes: a conceivable mode of action in treating hyper-proliferative skin diseases.

Autor: Laugesen IG, Hauge E, Andersen SM, Stenderup K, de Darkó E, Dam TN, Rosada C

Publikováno v: Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2013 Oct; Vol. 12 (10), pp. 1156-62.